Minor
Adjuvant Chemotherapy in Combination With Camrelizumab for Stage III Gastric Cancer (FOCUS-02)
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
Yu jirenPhase 2 NCT04515615 Registry history of NCT04515615 on ClinicalTrials.gov (opens the registry)
Changed